Literature DB >> 1360664

Isolation of transglutaminase-reactive sequences from complex biological systems: a prominent lysine donor sequence in bovine lens.

L Lorand1, P T Velasco, S N Murthy, J Wilson, K N Parameswaran.   

Abstract

The transglutaminase (protein-glutamine: amine gamma-glutamyltransferase, EC 2.3.2.13)-catalyzed cross-linking of proteins in biological systems can often be inhibited by inclusion of small primary amines or glutamine-containing peptides, which act as site-specific blockers of the relevant acceptor (i.e., glutamine) and donor (i.e., lysine) functionalities of the natural substrates. Compounds such as dansylcadaverine and dansyl-epsilon-aminocaproyl-Gln-Gln-Ile-Val are particularly useful in sorting out acceptor-donor relationships among lens crystallins. Apart from its fluorescent properties, the dansyl hapten offered special advantages as a "handle" for the rapid isolation of transglutaminase targets even in the complex system of lens cortical homogenate. The dansylated peptide was incorporated into bovine lens proteins under the influence of the Ca(2+)-activated intrinsic transglutaminase and, after digestion by endoproteinase Glu-C, the tracer-containing fragments were isolated by affinity chromatography on an anti-dansyl antibody column. The major fluorescent peak was isolated by HPLC and sequenced by Edman degradation, which yielded phenylthiohydantoin amino acid derivatives for the first 10 cycles, EKPAVTAAPK, and none for the next 2. The sequence, corresponding to residues 165-174 of alpha B-crystallin, unambiguously identifies the known carboxyl-terminal domain, EK-PAVTAAPKK, as the prominent lysine-donating fragment in bovine lens.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1360664      PMCID: PMC50509          DOI: 10.1073/pnas.89.23.11161

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  12 in total

1.  The carboxy-terminal lysine of alpha B-crystallin is an amine-donor substrate for tissue transglutaminase.

Authors:  P J Groenen; H Bloemendal; W W de Jong
Journal:  Eur J Biochem       Date:  1992-04-15

2.  Sorting-out of acceptor-donor relationships in the transglutaminase-catalyzed cross-linking of crystallins by the enzyme-directed labeling of potential sites.

Authors:  L Lorand; K N Parameswaran; P T Velasco
Journal:  Proc Natl Acad Sci U S A       Date:  1991-01-01       Impact factor: 11.205

Review 3.  Transglutaminases.

Authors:  L Lorand; S M Conrad
Journal:  Mol Cell Biochem       Date:  1984       Impact factor: 3.396

4.  Lens transglutaminase and cataract formation.

Authors:  L Lorand; L K Hsu; G E Siefring; N S Rafferty
Journal:  Proc Natl Acad Sci U S A       Date:  1981-03       Impact factor: 11.205

5.  Transamidating activities of factor XIIIa and of transglutaminases, measured by an ELISA procedure.

Authors:  P T Velasco; F Karush; L Lorand
Journal:  Biochem Biophys Res Commun       Date:  1988-04-29       Impact factor: 3.575

6.  Identification of transglutaminase substrates in inside-out vesicles from human erythrocytes: immunoblotting with anti-dansyl antibody.

Authors:  L Lorand; S N Murthy; P T Velasco; F Karush
Journal:  Biochem Biophys Res Commun       Date:  1986-01-29       Impact factor: 3.575

7.  Biotinylated peptides containing a factor XIIIa or a tissue transglutaminase-reactive glutaminyl residue that block protein cross-linking phenomena by becoming incorporated into amine donor sites.

Authors:  L Lorand; K N Parameswaran; P T Velasco; S N Murthy
Journal:  Bioconjug Chem       Date:  1992 Jan-Feb       Impact factor: 4.774

8.  Acceptor-donor relationships in the transglutaminase-mediated cross-linking of lens beta-crystallin subunits.

Authors:  P T Velasco; L Lorand
Journal:  Biochemistry       Date:  1987-07-28       Impact factor: 3.162

9.  Labeling of epsilon-lysine crosslinking sites in proteins with peptide substrates of factor XIIIa and transglutaminase.

Authors:  K N Parameswaran; P T Velasco; J Wilson; L Lorand
Journal:  Proc Natl Acad Sci U S A       Date:  1990-11       Impact factor: 11.205

10.  Cross-linking and proteolysis in Ca2(+)-treated lens homogenates.

Authors:  P T Velasco; P Murthy; D E Goll; L Lorand
Journal:  Biochim Biophys Acta       Date:  1990-09-03
View more
  8 in total

1.  Neurodegenerative diseases and transglutaminase.

Authors:  L Lorand
Journal:  Proc Natl Acad Sci U S A       Date:  1996-12-10       Impact factor: 11.205

2.  Enhanced expression of transglutaminase 2 in anterior polar cataracts and its induction by TGF-beta in vitro.

Authors:  X H Wan; E H Lee; H J Koh; J Song; E K Kim; C Y Kim; J B Lee; S-Y Kim; K Yao; J H Lee
Journal:  Br J Ophthalmol       Date:  2002-11       Impact factor: 4.638

3.  Age-dependent deamidation of lifelong proteins in the human lens.

Authors:  Peter G Hains; Roger J W Truscott
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-01-06       Impact factor: 4.799

4.  Exposure of beta H-crystallin to hydroxyl radicals enhances the transglutaminase-susceptibility of its existing amine-donor and amine-acceptor sites.

Authors:  P J Groenen; M Seccia; R H Smulders; E Gravela; K H Cheeseman; H Bloemendal; W W de Jong
Journal:  Biochem J       Date:  1993-10-15       Impact factor: 3.857

5.  Association of a transglutaminase-related antigen with intermediate filaments.

Authors:  A V Trejo-Skalli; P T Velasco; S N Murthy; L Lorand; R D Goldman
Journal:  Proc Natl Acad Sci U S A       Date:  1995-09-12       Impact factor: 11.205

6.  Signature Ions in MS/MS Spectra for Dansyl-Aminohexyl-QQIV Adducts on Lysine.

Authors:  Lawrence M Schopfer; Oksana Lockridge
Journal:  Molecules       Date:  2020-06-08       Impact factor: 4.411

7.  Neurophysiological and behavioural effects of conventional and high definition tDCS.

Authors:  Fabio Masina; Giorgio Arcara; Eleonora Galletti; Isabella Cinque; Luciano Gamberini; Daniela Mapelli
Journal:  Sci Rep       Date:  2021-04-07       Impact factor: 4.379

8.  Transglutaminase 2 promotes tumorigenicity of colon cancer cells by inactivation of the tumor suppressor p53.

Authors:  Patrizia Malkomes; Ilaria Lunger; Elsie Oppermann; Khalil Abou-El-Ardat; Thomas Oellerich; Stefan Günther; Can Canbulat; Sabrina Bothur; Frank Schnütgen; Weijia Yu; Susanne Wingert; Nadine Haetscher; Claudia Catapano; Marina S Dietz; Mike Heilemann; Hans-Michael Kvasnicka; Katharina Holzer; Hubert Serve; Wolf Otto Bechstein; Michael A Rieger
Journal:  Oncogene       Date:  2021-06-08       Impact factor: 9.867

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.